UK-based subsidiary Jaguar Land Rover (JLR) reported a sharp decline in second-quarter sales, hit by a cyber incident and the ...
EMC solutions provider EMIS announces the availability of the TPQH3411 passive harmonic filter designed to provide a cost ...
Northwestern University professor Hande Ozdinler is hoping to change how ALS is treated, saying the disease is too complex ...
In recent months, the refreshed Tesla Model Y has also been seeing an uptick in sales, with September making it the ...
Clinical Trials Arena on MSN
Bayer’s cell therapy shows 3-year improvement in Phase I Parkinson’s trial
The drug will now progress to pivotal Phase III trials after demonstrating trends towards a disease-modifying impact.
Stage Two dewatering advancing on schedule; approximately 20% complete Start-up of Africa’s largest copper smelter to ...
The city of Aurora is looking to finish the construction of a new well at Fire Station 10 with the purchase of a new pump and ...
While AMT-130 could result in meaningful revenue for ClearPoint, the Huntington's opportunity is relatively modest compared ...
Stockhead on MSN
Health Check: Neurizon free to advance motor neurone disease trial after FDA lifts ‘clinical hold’
Neurizon Therapeutics is free to advance the next clinical trial of its candidate to treat amyotrophic lateral sclerosis (ALS ...
Sarepta Therapeutics is showing signs of recovery, driven by its robust pipeline and recent revenue growth, despite past ...
Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday. A total of 106 patients with short ...
Market expert Ankush Bajaj recommends three PSU bank stocks to buy on 6 October. Discover his exclusive picks and analysis to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback